Entity Common Stock, Shares Outstanding of Xeris Biopharma Holdings, Inc. from 31 Oct 2021 to 27 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Xeris Biopharma Holdings, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Oct 2021 to 27 Feb 2026.
  • Xeris Biopharma Holdings, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 27 Feb 2026 was 172,431,290, a 7.7% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Xeris Biopharma Holdings, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 172,431,290 +12,276,290 +7.7% 27 Feb 2026 10-K 02 Mar 2026 2025 FY
Q3 2025 165,924,289 +16,842,828 +11% 31 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 161,480,367 +12,481,542 +8.4% 31 Jul 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 160,155,000 +11,899,337 +8% 30 Apr 2025 10-Q 08 May 2025 2025 Q1
Q3 2024 149,081,461 +10,956,866 +7.9% 31 Oct 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 148,998,825 +10,932,832 +7.9% 31 Jul 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 148,255,663 +10,944,195 +8% 30 Apr 2024 10-Q 09 May 2024 2024 FY
Q3 2023 138,124,595 +2,139,505 +1.6% 31 Oct 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 138,065,993 +2,108,713 +1.6% 31 Jul 2023 10-Q 08 Aug 2023 2023 FY
Q1 2023 137,311,468 +1,780,712 +1.3% 01 May 2023 10-Q 09 May 2023 2023 FY
Q3 2022 135,985,090 +11,276,155 +9% 31 Oct 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 135,957,280 31 Jul 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 135,530,756 30 Apr 2022 10-Q 11 May 2022 2022 Q1
Q3 2021 124,708,935 31 Oct 2021 10-Q 10 Nov 2021 2021 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.